Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Monte Rosa Therapeutics Inc have a median target of 15.00, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a 77.30% increase from the last price of 8.46.
High | 136.4% | 20.00 |
Med | 77.3% | 15.00 |
Low | 65.5% | 14.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | +19.30% |
Average growth rate | +3.97% |
More ▼
Revenue history & estimates in USD
Average growth rate | +145.85% |
Average growth rate | 0.00% |
More ▼